“Albutrepenonacog Alfa (Idelvion®) for the Treatment of Italian Patients With Hemophilia B: A Budget Impact Model”. 2018. Farmeconomia. Health Economics and Therapeutic Pathways 19 (1). https://doi.org/10.7175/fe.v19i1.1328.